CCL18 and bacterial urinary tract infection: In the present study, by comparing UC patients to individuals with benign urinary tract conditions rather than healthy controls, our results further suggest that elevated CCL18 expression may serve as a potential biomarker for distinguishing hematuria and UTI from UCs.